US20040118802A1 - Safety seal for potent product - Google Patents
Safety seal for potent product Download PDFInfo
- Publication number
- US20040118802A1 US20040118802A1 US10/324,658 US32465802A US2004118802A1 US 20040118802 A1 US20040118802 A1 US 20040118802A1 US 32465802 A US32465802 A US 32465802A US 2004118802 A1 US2004118802 A1 US 2004118802A1
- Authority
- US
- United States
- Prior art keywords
- container
- pharmaceutical
- safety seal
- placing
- sealing portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D41/00—Caps, e.g. crown caps or crown seals, i.e. members having parts arranged for engagement with the external periphery of a neck or wall defining a pouring opening or discharge aperture; Protective cap-like covers for closure members, e.g. decorative covers of metal foil or paper
- B65D41/02—Caps or cap-like covers without lines of weakness, tearing strips, tags, or like opening or removal devices
- B65D41/22—Caps or cap-like covers with elastic parts adapted to be stretched over the container
Definitions
- the present disclosure relates to pharmaceutical containers and, in particular, to safety seals surrounding at least a portion of the pharmaceutical container.
- a problem of growing concern among health care workers and pharmaceutical manufacturing personal is the risk of injury and disease resulting from the handling of pharmaceuticals or hazardous products, especially those having high levels of toxicity such as certain cancer chemotherapy drugs and other dangerous substances.
- the degree of risk to workers handling these toxic pharmaceuticals is dependent upon the drugs' inherent toxicity and the extent to which workers are exposed to the pharmaceuticals.
- the degree of toxicity from accidental dosages is not well understood or known, and the effects of slight exposure over long time periods are unpredictable.
- Exposure to toxic pharmaceuticals can be a result of inhalation of airborne dusts from recrystalized pharmaceuticals or of airborne droplets, absorption of pharmaceuticals through the skin, lungs, and mucous membranes from accidental contact, and ingestion of pharmaceuticals with food, beverages, and the like that have been contaminated through accidental contact with the pharmaceutical.
- a pharmaceutical container includes a vial, a sealing portion, an over cap portion, and a safety seal.
- the vial includes a first vial portion having a first surface.
- the vial is configured and arranged to hold a pharmaceutical product.
- the sealing portion includes a first stopper portion and a second stopper portion, the second stopper portion is positioned in the first vial portion and the first stopper portion rests against the first surface.
- the over cap portion surrounds the sealing portion and secures the first stopper portion against the first surface.
- the safety seal encapsulates at least the over cap portion to prevent accidental contact with any pharmaceutical product that might be present on the over cap portion or the total package.
- a method of manufacturing a pharmaceutical container includes filling a pharmaceutical vial with a pharmaceutical product; placing a sealing portion into the pharmaceutical vial; placing an over cap portion around the sealing portion to secure the sealing portion in the pharmaceutical vial; and placing a safety seal around at least the over cap portion to prevent accidental contact with any pharmaceutical product that might be present on at least the over cap portion.
- a method of removing a pharmaceutical product from a container includes placing a needle through a safety seal and a stopper of the container; and removing the pharmaceutical product from the container through the needle.
- FIG. 1 is a perspective view of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 2 is a front view of the pharmaceutical container of FIG. 1 in accordance with the present disclosure.
- FIG. 3 is a cross-sectional view of the pharmaceutical container of FIG. 2, taken along lines 3 - 3 , in accordance with the present disclosure.
- FIG. 4 is a cross-sectional view of a pharmaceutical container without a safety seal, in accordance with the present disclosure.
- FIG. 5 is a cross-sectional view of another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 6 is a front view of another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 7 is a front view of yet another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 8 is a perspective view of another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- the present disclosure relates to safety-seals for pharmaceutical containers.
- the safety seals are configured and arranged to protect a handler, or a person, of the pharmaceutical container from accidental contact with any pharmaceutical, or hazardous material, that might be left on the outside of the pharmaceutical container after filling.
- Such safety seals include vial prophylactics or condoms; sealing wax; dipped-on, paint-on, or spray-on rubbers, rubber-like materials, polymers, or polymer-like materials; shrink wrap; and other like devices.
- the pharmaceutical container 10 includes a pharmaceutical vial portion, or container, 12 and a safety seal 14 .
- the pharmaceutical container 10 is not limited to vials; for example, the pharmaceutical container 10 can be a syringe, ampoule, cartridge, or other container.
- FIG. 3 is a cross-sectional view of the pharmaceutical container 10 of FIG. 2, taken along lines 3 - 3 .
- the pharmaceutical container 10 includes the pharmaceutical vial portion 12 .
- the pharmaceutical vial portion 12 includes a pharmaceutical vial 15 having a first portion 16 and a second portion 18 .
- the first portion 16 is typically a top portion 20 of the pharmaceutical vial 15 .
- the top portion 20 includes a top 22 , a neck 24 , and a transition area 26 .
- the top 22 is typically circular and defines an opening 28 .
- the top 22 has a first diameter D 1 between 0.5 inches and 1.3 inches.
- the opening 28 has a second diameter D 2 that is preferably less than D 1 .
- the second diameter D 2 is between 0.3 inches and 0.9 inches.
- any suitable diameter can be used.
- the neck 24 is also typically circular and continues to define the opening 28 .
- the neck 24 has a third diameter D 3 .
- the third diameter D 3 is generally less than the first diameter D 1 and greater than the second diameter D 2 .
- the third diameter D 3 is between 0.4 inches and 1.4 inches.
- any suitable diameter can be used.
- the difference between the third diameter D 3 and the second diameter D 2 is the thickness 29 , or neck wall, of the neck 24 .
- the top 22 further includes an underside portion 30 between the outside circumference 32 of the top 22 and the outside circumference 34 of the neck 24 .
- the top 22 also includes a topside portion, or surface, 35 .
- the second portion 18 is typically a bottom portion 36 of the pharmaceutical vial 15 .
- the bottom portion 36 is generally circular having a fourth diameter D 4 .
- the fourth diameter D 4 is between 0.5 inches and 3.4 inches.
- the bottom portion 36 defines an inner portion 38 .
- the inner portion 38 contains a pharmaceutical product 40 .
- the inner portion 38 has a fifth diameter D 5 that is less than the fourth diameter D 4 .
- the fifth diameter D 5 is between 0.4 inches and 3.2 inches. Of course, any suitable diameter can be used.
- the bottom portion 36 includes a vial wall 42 .
- the top portion 20 includes the transition area 26 .
- the transition area 26 is a transition between the neck 24 and the bottom portion 36 .
- the transition area 26 is generally configured of a series of reverse arcs as illustrated. Of course, the transition area 26 can have any suitable configuration.
- the pharmaceutical vial 15 can be constructed of any suitable material, and preferably, the pharmaceutical vial 15 comprises glass.
- the pharmaceutical container might also comprise a polymer-type material or any other material.
- the pharmaceutical vial 15 can also be configured and arranged differently than that illustrated in FIGS. 1, 2, and 3 , for example, an ampoule, syringe, or cartridge.
- the pharmaceutical vial portion 12 further includes a sealing portion 50 .
- the sealing portion 50 is configured and arranged to substantially seal the pharmaceutical product 40 in the pharmaceutical vial 15 .
- substantially seal it is meant, if the process is in control, that leakage past the seal of any container is a rare event.
- the sealing portion 50 includes a stopper 52 that is configured and arranged to fit within the first portion 16 of the pharmaceutical vial 15 .
- the stopper 52 includes a first stopper portion 54 and a second stopper portion 56 .
- the second stopper portion 56 is configured and arranged to fit into the opening 28 of the top 22 and into the opening 28 of the neck 24 .
- the second stopper portion 56 has a sixth diameter D 6 that is approximately equal to the second diameter D 2 .
- the stopper 52 is comprised of a material that is compressible, such as rubber, so that the sixth diameter D 6 of the second stopper portion 56 is slightly compressed when placed within the opening 28 . This compression helps to create the substantial seal that retains the pharmaceutical product 40 within the bottom portion 36 of the pharmaceutical vial 15 when the stopper 52 is properly seated.
- the second stopper portion 56 is inserted into the opening 28 of the top 22 and the neck 24 until the first stopper portion 54 comes to rest against the topside surface 35 of the top 22 .
- the sealing portion 50 can be constructed of any suitable material, but is typically constructed of a compressible material and a material that substantially seals the pharmaceutical product 40 within the pharmaceutical vial 15 .
- the pharmaceutical vial portion 12 further includes an over cap portion, or ring portion, 70 .
- the over cap portion 70 is designed and configured to retain the sealing portion 50 in the pharmaceutical vial 15 .
- the over cap portion 70 includes an over cap, or ring, 72 .
- the over cap portion 70 can be other types of devices designed to retain the sealing portion 50 in the pharmaceutical vial 15 , for example, a line-seal, a screw-type cap, or a snap cap.
- the over cap 72 wraps around the sealing portion 50 and the underside surface 30 of the top 22 of the pharmaceutical vial 15 .
- the over cap 72 sandwiches the sealing portion 50 against the topside surface 35 of the top 22 of the pharmaceutical vial 15 and keeps the sealing portion 50 slightly compressed against the topside surface 35 of the top 22 of the pharmaceutical vial 15 .
- This slightly compressed state helps substantially seal the pharmaceutical product 40 within the pharmaceutical vial 15 .
- the over cap 72 clamps the stopper 52 onto the pharmaceutical vial 15 and prevents the sealing portion 50 from dislodging from the pharmaceutical vial 15 .
- the over cap 72 is typically crimped-on in a conventional manner.
- the over cap 72 defines a second opening 74 having a seventh diameter D 7 .
- the seventh diameter D 7 is slightly smaller than the second diameter D 2 .
- the second opening 74 allows a needle to pass through and into the vial 15 for removal of the product 40 .
- the over cap 72 can comprise any suitable material, but typically comprises aluminum or a plastic material.
- the pharmaceutical container 10 further includes the safety seal 14 .
- the safety seal 14 is configured and arranged to protect a handler, or a person, of the pharmaceutical container 10 from accidental contact with any pharmaceutical, or hazardous material, that might be left on the outside of the pharmaceutical container 10 after filling.
- the safety seal 14 is configured and arranged to surround or encapsulate the over cap portion 70 , and a part of neck 24 of the pharmaceutical vial 15 .
- the safety seal 14 is designed to enclose any particles that might be present on the outside surfaces of the over cap portion 70 and the part of the neck 24 of the pharmaceutical vial 15 after filling of the pharmaceutical product 40 into the pharmaceutical vial 15 .
- the safety seal 14 protects a person, such as operators, handlers, inspectors, nurses, doctors, and the like, from accidental contact with a pharmaceutical product, such as a harmful or toxic pharmaceutical product.
- the safety seal 14 can comprise any suitable material, but preferably is a latex-type material.
- the safety seal 14 can be other materials as well, such as a sealing wax, paint-on rubber, or a shrink-wrap cap.
- the safety seal 14 can have other configurations as well, in addition to that illustrated in FIGS. 1, 2, and 3 . Referring to FIG. 5, an entire pharmaceutical vial portion 112 can be completely encased with a safety seal 114 .
- the pharmaceutical container 210 includes a safety seal 214 and a pharmaceutical vial 215 .
- the pharmaceutical container 210 is packaged in a blister package 220 .
- the blister package 220 serves to keep people from coming into contact with toxic product directly or indirectly.
- the blister package 220 itself can be the safety seal 214 instead of a separate safety seal 214 and blister package 220 .
- the blister package 220 is conventional and includes a backing, Lidding foil, or Lidding material 222 and an overlay, forming film, or forming material 224 .
- the backing 222 comprises a foil or cardboard like substance
- the overlay 224 comprises a polymer, such as plastic.
- any suitable material, insert, or lamination combination can be used for both the backing 222 and the overlay 224 .
- the pharmaceutical container 310 includes a safety seal 314 and a pharmaceutical vial 315 .
- the pharmaceutical container 310 is packaged in a form, fill, and seal package 320 .
- the form, fill, and seal package 320 itself can be the safety seal 314 instead of a separate safety seal 314 and form, fill, and seal package 320 .
- the form, fill, and seal package 320 serves to keep people from coming into contact with toxic product directly or indirectly.
- the form, fill, and seal package 320 is conventional and typically comprises a polymer, such as plastic. Typically, the form, fill, and seal package 320 is flexible. Of course, any suitable material or combination of laminations can be used for form, fill, and seal package 320 .
- the pharmaceutical container 310 might also include a conventional plastic flip cap that can be removed from the pharmaceutical vial 315 before use through the form, fill, and seal package 320 without opening the form, fill, and seal package 320 .
- the pharmaceutical vial 15 is filled with a pharmaceutical product 40 .
- the second portion 56 of the stopper 52 is press fitted into the opening 28 of the top 22 and the neck 24 of the pharmaceutical vial 15 until the first portion 54 of the stopper 52 rests against, or comes in contact with, the topside surface 35 of the top 22 of the pharmaceutical vial 15 .
- the over cap 72 is crimped-on over the stopper 52 to hold it in place and substantially seal the pharmaceutical product 40 within the pharmaceutical vial 15 .
- the safety seal 14 is then placed around the over cap 72 and a portion of the neck 24 to prevent accidental contact with any particles of the pharmaceutical product 40 that might be on the outside of the over cap 72 and a portion of the neck 24 or the total package.
- the pharmaceutical container 10 with the safety seal 14 is then thoroughly washed to remove any trace of toxic pharmaceutical or hazardous substance left outside the safety seal 14 .
- other methods of manufacture can be used without deviating from the scope of the present disclosure.
- a needle is poked through the safety seal 14 and through the second opening 74 in the over cap 72 and through the stopper 52 .
- the pharmaceutical product 40 is withdrawn from the pharmaceutical vial 15 via a needle, typically into a syringe.
- a blister package such as the blister package 220 of FIG. 6, the needle can be poked through the blister package 220 . Then the above-described method can be used to remove the product from the pharmaceutical vial 215 .
- a form, fill, and seal package such as the form, fill, and seal package 320 of FIG. 7, is used, the needle can be poked through the form, fill, and seal package 320 . Then the above-described method can be used to remove the product from the pharmaceutical vial 315 .
- the pharmaceutical container 410 includes a safety seal 414 and a pharmaceutical vial 415 .
- the pharmaceutical container 10 includes a convention flip cap 420 . After manufacture, the flip cap 420 is generally integral with an over cap 422 .
- the safety seal 414 is loose at the top portion of the pharmaceutical container 410 .
- a person flips off the flip cap 420 by placing a finger on the flip cap 420 and flipping it off.
- the safety seal 414 is loose enough to although the flip cap 420 to be removed without penetrating the safety seal 414 .
- a needle can then be poked through the safety seal 414 , and a stopper 424 , now exposed by removal of the flip cap 420 , and into the pharmaceutical vial 415 to remove a product.
Abstract
A pharmaceutical container includes a vial, a sealing portion, an over cap portion, and a safety seal. The vial includes a first vial portion having a first surface. The vial is configured and arranged to hold a pharmaceutical product. The sealing portion includes a first stopper portion and a second stopper portion, the second stopper portion is positioned in the first vial portion and the first stopper portion rests against the first surface. The over cap portion surrounds the sealing portion and secures the first stopper portion against the first surface. The safety seal encapsulates at least the over cap portion to prevent accidental contact with any pharmaceutical product that might be present on the over cap portion. A method of manufacturing a pharmaceutical container includes filling a pharmaceutical vial with a pharmaceutical product; placing a sealing portion onto the pharmaceutical vial; placing an over cap portion around the sealing portion to secure the sealing portion in the pharmaceutical vial; and placing a safety seal around at least the over cap portion to prevent accidental contact with any pharmaceutical product that might be present on at least the over cap portion. A method of removing a pharmaceutical product from a container includes placing a needle through a safety seal and a stopper of the container; and removing the pharmaceutical product from the container through the needle.
Description
- The present disclosure relates to pharmaceutical containers and, in particular, to safety seals surrounding at least a portion of the pharmaceutical container.
- A problem of growing concern among health care workers and pharmaceutical manufacturing personal is the risk of injury and disease resulting from the handling of pharmaceuticals or hazardous products, especially those having high levels of toxicity such as certain cancer chemotherapy drugs and other dangerous substances. The degree of risk to workers handling these toxic pharmaceuticals is dependent upon the drugs' inherent toxicity and the extent to which workers are exposed to the pharmaceuticals. For some pharmaceuticals, the degree of toxicity from accidental dosages is not well understood or known, and the effects of slight exposure over long time periods are unpredictable.
- Exposure to toxic pharmaceuticals can be a result of inhalation of airborne dusts from recrystalized pharmaceuticals or of airborne droplets, absorption of pharmaceuticals through the skin, lungs, and mucous membranes from accidental contact, and ingestion of pharmaceuticals with food, beverages, and the like that have been contaminated through accidental contact with the pharmaceutical.
- In particular, after manufacture of certain toxic pharmaceuticals, a small amount of pharmaceuticals might be left on the outside of the container containing the pharmaceutical. Accidental contact with this small amount can be harmful and even dangerous to a person. Therefore, improvements are desirable.
- In accordance with the present disclosure, the above and other problems are solved by the following:
- In one aspect of the present disclosure, a pharmaceutical container includes a vial, a sealing portion, an over cap portion, and a safety seal. The vial includes a first vial portion having a first surface. The vial is configured and arranged to hold a pharmaceutical product. The sealing portion includes a first stopper portion and a second stopper portion, the second stopper portion is positioned in the first vial portion and the first stopper portion rests against the first surface. The over cap portion surrounds the sealing portion and secures the first stopper portion against the first surface. The safety seal encapsulates at least the over cap portion to prevent accidental contact with any pharmaceutical product that might be present on the over cap portion or the total package.
- In another aspect of the present disclosure, a method of manufacturing a pharmaceutical container includes filling a pharmaceutical vial with a pharmaceutical product; placing a sealing portion into the pharmaceutical vial; placing an over cap portion around the sealing portion to secure the sealing portion in the pharmaceutical vial; and placing a safety seal around at least the over cap portion to prevent accidental contact with any pharmaceutical product that might be present on at least the over cap portion.
- In another aspect of the present disclosure, a method of removing a pharmaceutical product from a container includes placing a needle through a safety seal and a stopper of the container; and removing the pharmaceutical product from the container through the needle.
- The features and the advantages of the present disclosure are described more completely below in conjunction with the accompanying drawings in which like parts are identified by like numerals and wherein:
- FIG. 1 is a perspective view of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 2 is a front view of the pharmaceutical container of FIG. 1 in accordance with the present disclosure.
- FIG. 3 is a cross-sectional view of the pharmaceutical container of FIG. 2, taken along lines3-3, in accordance with the present disclosure.
- FIG. 4 is a cross-sectional view of a pharmaceutical container without a safety seal, in accordance with the present disclosure.
- FIG. 5 is a cross-sectional view of another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 6 is a front view of another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 7 is a front view of yet another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- FIG. 8 is a perspective view of another embodiment of a pharmaceutical container having a safety seal in accordance with the present disclosure.
- In general, the present disclosure relates to safety-seals for pharmaceutical containers. The safety seals are configured and arranged to protect a handler, or a person, of the pharmaceutical container from accidental contact with any pharmaceutical, or hazardous material, that might be left on the outside of the pharmaceutical container after filling. Such safety seals include vial prophylactics or condoms; sealing wax; dipped-on, paint-on, or spray-on rubbers, rubber-like materials, polymers, or polymer-like materials; shrink wrap; and other like devices.
- Referring to FIGS. 1 and 2, a pharmaceutical container, or package,10 is illustrated. The
pharmaceutical container 10 includes a pharmaceutical vial portion, or container, 12 and asafety seal 14. Thepharmaceutical container 10 is not limited to vials; for example, thepharmaceutical container 10 can be a syringe, ampoule, cartridge, or other container. - FIG. 3 is a cross-sectional view of the
pharmaceutical container 10 of FIG. 2, taken along lines 3-3. Thepharmaceutical container 10 includes thepharmaceutical vial portion 12. In general, thepharmaceutical vial portion 12 includes apharmaceutical vial 15 having afirst portion 16 and asecond portion 18. Thefirst portion 16 is typically atop portion 20 of thepharmaceutical vial 15. Thetop portion 20 includes atop 22, aneck 24, and atransition area 26. - The
top 22 is typically circular and defines anopening 28. Preferably, thetop 22 has a first diameter D1 between 0.5 inches and 1.3 inches. Of course, any suitable diameter can be used. The opening 28 has a second diameter D2 that is preferably less than D1. Preferably, the second diameter D2 is between 0.3 inches and 0.9 inches. Of course, any suitable diameter can be used. - The
neck 24 is also typically circular and continues to define theopening 28. Theneck 24 has a third diameter D3. The third diameter D3 is generally less than the first diameter D1 and greater than the second diameter D2. Preferably, the third diameter D3 is between 0.4 inches and 1.4 inches. Of course, any suitable diameter can be used. The difference between the third diameter D3 and the second diameter D2 is thethickness 29, or neck wall, of theneck 24. - The
top 22 further includes anunderside portion 30 between theoutside circumference 32 of thetop 22 and theoutside circumference 34 of theneck 24. The top 22 also includes a topside portion, or surface, 35. - The
second portion 18 is typically abottom portion 36 of thepharmaceutical vial 15. Thebottom portion 36 is generally circular having a fourth diameter D4. Preferably, the fourth diameter D4 is between 0.5 inches and 3.4 inches. Of course, any suitable diameter can be used. Thebottom portion 36 defines aninner portion 38. Theinner portion 38 contains apharmaceutical product 40. Theinner portion 38 has a fifth diameter D5 that is less than the fourth diameter D4. Preferably, the fifth diameter D5 is between 0.4 inches and 3.2 inches. Of course, any suitable diameter can be used. Thebottom portion 36 includes avial wall 42. - The
top portion 20 includes thetransition area 26. Thetransition area 26 is a transition between theneck 24 and thebottom portion 36. Thetransition area 26 is generally configured of a series of reverse arcs as illustrated. Of course, thetransition area 26 can have any suitable configuration. - The
pharmaceutical vial 15 can be constructed of any suitable material, and preferably, thepharmaceutical vial 15 comprises glass. The pharmaceutical container might also comprise a polymer-type material or any other material. One skilled in the art will appreciate that thepharmaceutical vial 15 can also be configured and arranged differently than that illustrated in FIGS. 1, 2, and 3, for example, an ampoule, syringe, or cartridge. - The
pharmaceutical vial portion 12 further includes a sealingportion 50. In general, the sealingportion 50 is configured and arranged to substantially seal thepharmaceutical product 40 in thepharmaceutical vial 15. By the term “substantially seal,” it is meant, if the process is in control, that leakage past the seal of any container is a rare event. - The sealing
portion 50 includes astopper 52 that is configured and arranged to fit within thefirst portion 16 of thepharmaceutical vial 15. Of course, other suitable sealing devices can be used, such as a disc of sealing material. Thestopper 52 includes afirst stopper portion 54 and asecond stopper portion 56. Thesecond stopper portion 56 is configured and arranged to fit into theopening 28 of the top 22 and into theopening 28 of theneck 24. As such, thesecond stopper portion 56 has a sixth diameter D6 that is approximately equal to the second diameter D2. Preferably, thestopper 52 is comprised of a material that is compressible, such as rubber, so that the sixth diameter D6 of thesecond stopper portion 56 is slightly compressed when placed within theopening 28. This compression helps to create the substantial seal that retains thepharmaceutical product 40 within thebottom portion 36 of thepharmaceutical vial 15 when thestopper 52 is properly seated. - The
second stopper portion 56 is inserted into theopening 28 of the top 22 and theneck 24 until thefirst stopper portion 54 comes to rest against thetopside surface 35 of the top 22. Of course, the sealingportion 50 can be constructed of any suitable material, but is typically constructed of a compressible material and a material that substantially seals thepharmaceutical product 40 within thepharmaceutical vial 15. - The
pharmaceutical vial portion 12 further includes an over cap portion, or ring portion, 70. The overcap portion 70 is designed and configured to retain the sealingportion 50 in thepharmaceutical vial 15. The overcap portion 70 includes an over cap, or ring, 72. Of course, the overcap portion 70 can be other types of devices designed to retain the sealingportion 50 in thepharmaceutical vial 15, for example, a line-seal, a screw-type cap, or a snap cap. - The over
cap 72 wraps around the sealingportion 50 and theunderside surface 30 of the top 22 of thepharmaceutical vial 15. The overcap 72 sandwiches the sealingportion 50 against thetopside surface 35 of the top 22 of thepharmaceutical vial 15 and keeps the sealingportion 50 slightly compressed against thetopside surface 35 of the top 22 of thepharmaceutical vial 15. This slightly compressed state helps substantially seal thepharmaceutical product 40 within thepharmaceutical vial 15. The overcap 72 clamps thestopper 52 onto thepharmaceutical vial 15 and prevents the sealingportion 50 from dislodging from thepharmaceutical vial 15. During manufacture, the overcap 72 is typically crimped-on in a conventional manner. - Referring to FIG. 4, the over
cap 72 defines asecond opening 74 having a seventh diameter D7. Preferably, the seventh diameter D7 is slightly smaller than the second diameter D2. Thesecond opening 74 allows a needle to pass through and into thevial 15 for removal of theproduct 40. The overcap 72 can comprise any suitable material, but typically comprises aluminum or a plastic material. - The
pharmaceutical container 10 further includes thesafety seal 14. Thesafety seal 14 is configured and arranged to protect a handler, or a person, of thepharmaceutical container 10 from accidental contact with any pharmaceutical, or hazardous material, that might be left on the outside of thepharmaceutical container 10 after filling. - Preferably, the
safety seal 14 is configured and arranged to surround or encapsulate the overcap portion 70, and a part ofneck 24 of thepharmaceutical vial 15. In general, thesafety seal 14 is designed to enclose any particles that might be present on the outside surfaces of the overcap portion 70 and the part of theneck 24 of thepharmaceutical vial 15 after filling of thepharmaceutical product 40 into thepharmaceutical vial 15. In general, thesafety seal 14 protects a person, such as operators, handlers, inspectors, nurses, doctors, and the like, from accidental contact with a pharmaceutical product, such as a harmful or toxic pharmaceutical product. Thesafety seal 14 can comprise any suitable material, but preferably is a latex-type material. Thesafety seal 14 can be other materials as well, such as a sealing wax, paint-on rubber, or a shrink-wrap cap. - The
safety seal 14 can have other configurations as well, in addition to that illustrated in FIGS. 1, 2, and 3. Referring to FIG. 5, an entirepharmaceutical vial portion 112 can be completely encased with asafety seal 114. - Referring to FIG. 6, another example embodiment of a
pharmaceutical container 210 is illustrated. In this example embodiment, thepharmaceutical container 210 includes asafety seal 214 and apharmaceutical vial 215. Thepharmaceutical container 210 is packaged in ablister package 220. Theblister package 220 serves to keep people from coming into contact with toxic product directly or indirectly. Of course, theblister package 220 itself can be thesafety seal 214 instead of aseparate safety seal 214 andblister package 220. - The
blister package 220 is conventional and includes a backing, Lidding foil, orLidding material 222 and an overlay, forming film, or formingmaterial 224. Typically, thebacking 222 comprises a foil or cardboard like substance, and theoverlay 224 comprises a polymer, such as plastic. Of course, any suitable material, insert, or lamination combination can be used for both thebacking 222 and theoverlay 224. - Referring to FIG. 7, another example embodiment of a
pharmaceutical container 310 is illustrated. In this example embodiment, thepharmaceutical container 310 includes asafety seal 314 and apharmaceutical vial 315. Thepharmaceutical container 310 is packaged in a form, fill, andseal package 320. Of course, the form, fill, andseal package 320 itself can be thesafety seal 314 instead of aseparate safety seal 314 and form, fill, andseal package 320. The form, fill, andseal package 320 serves to keep people from coming into contact with toxic product directly or indirectly. - The form, fill, and
seal package 320 is conventional and typically comprises a polymer, such as plastic. Typically, the form, fill, andseal package 320 is flexible. Of course, any suitable material or combination of laminations can be used for form, fill, andseal package 320. - In this embodiment, the
pharmaceutical container 310 might also include a conventional plastic flip cap that can be removed from thepharmaceutical vial 315 before use through the form, fill, andseal package 320 without opening the form, fill, andseal package 320. - During manufacture, the
pharmaceutical vial 15 is filled with apharmaceutical product 40. Thesecond portion 56 of thestopper 52 is press fitted into theopening 28 of the top 22 and theneck 24 of thepharmaceutical vial 15 until thefirst portion 54 of thestopper 52 rests against, or comes in contact with, thetopside surface 35 of the top 22 of thepharmaceutical vial 15. The overcap 72 is crimped-on over thestopper 52 to hold it in place and substantially seal thepharmaceutical product 40 within thepharmaceutical vial 15. Thesafety seal 14 is then placed around the overcap 72 and a portion of theneck 24 to prevent accidental contact with any particles of thepharmaceutical product 40 that might be on the outside of the overcap 72 and a portion of theneck 24 or the total package. Thepharmaceutical container 10 with thesafety seal 14 is then thoroughly washed to remove any trace of toxic pharmaceutical or hazardous substance left outside thesafety seal 14. Of course, other methods of manufacture can be used without deviating from the scope of the present disclosure. - During use, a needle is poked through the
safety seal 14 and through thesecond opening 74 in the overcap 72 and through thestopper 52. Thepharmaceutical product 40 is withdrawn from thepharmaceutical vial 15 via a needle, typically into a syringe. When a blister package, such as theblister package 220 of FIG. 6, the needle can be poked through theblister package 220. Then the above-described method can be used to remove the product from thepharmaceutical vial 215. Similarly, when a form, fill, and seal package, such as the form, fill, andseal package 320 of FIG. 7, is used, the needle can be poked through the form, fill, andseal package 320. Then the above-described method can be used to remove the product from thepharmaceutical vial 315. - Referring to FIG. 8, another example embodiment of a
pharmaceutical container 410 is illustrated. In this example embodiment, thepharmaceutical container 410 includes asafety seal 414 and apharmaceutical vial 415. In this embodiment thepharmaceutical container 10 includes aconvention flip cap 420. After manufacture, theflip cap 420 is generally integral with an overcap 422. In this embodiment, thesafety seal 414 is loose at the top portion of thepharmaceutical container 410. - During use, a person flips off the
flip cap 420 by placing a finger on theflip cap 420 and flipping it off. Thesafety seal 414 is loose enough to although theflip cap 420 to be removed without penetrating thesafety seal 414. A needle can then be poked through thesafety seal 414, and astopper 424, now exposed by removal of theflip cap 420, and into thepharmaceutical vial 415 to remove a product. - It is noted that while the above ideas regarding a safety-seal are generally described with regard to pharmaceutical containers, the invention can be applied to any suitable container for which accidental contact with a product might be of concern.
- Although specific embodiments of the present invention have been described and illustrated, it will be appreciated by those skilled in the art that many variations of the designs described can be practiced within the scope of the present disclosure, and that all such variations are contemplated within the teaching of the present disclosure. Accordingly, the scope of the disclosure is not limited to the specific embodiments shown, but is limited only by the scope of the following claims.
Claims (24)
1. A pharmaceutical package comprising:
a container including a first container portion having a first surface, the container being configured and arranged to hold a pharmaceutical product;
a sealing portion having a first sealing portion and a second sealing portion, the second sealing portion being positioned in the first container portion and the first sealing portion being in contact with the first surface; and
a safety seal encapsulating at least a portion of the container to prevent accidental contact with any pharmaceutical product that might be present on the portion of the container.
2. A pharmaceutical container according to claim 1 , wherein the safety seal comprises a latex-type material.
3. A pharmaceutical container according to claim 1 , wherein the safety seal comprises a sealing wax.
4. A pharmaceutical container according to claim 1 , wherein the safety seal comprises a paint-on, spray-on, dipped rubber, rubber-like material, polymer, or polymer-like material.
5. A pharmaceutical container according to claim 1 , wherein the safety seal comprises a shrink wrap.
6. A pharmaceutical container according to claim 1 , wherein the safety-seal encapsulates the entire container.
7. A pharmaceutical container according to claim 1 , wherein the safety seal is a blister package.
8. A pharmaceutical container according to claim 1 , wherein the safety seal is a form, fill, and seal package.
9. A pharmaceutical container according to claim 8 , wherein the form, fill, and seal package is a flexible bag.
10. A pharmaceutical container according to claim 1 , wherein the sealing portion is a stopper.
11. A pharmaceutical container according to claim 1 , wherein the sealing portion is a disc of sealing material.
12. A pharmaceutical container according to claim 1 , further comprising an over cap portion around the sealing portion to secure the first sealing portion against the first surface.
13. A pharmaceutical container according to claim 12 , further including a flip cap integral with the over cap.
14. A pharmaceutical container wherein the container is a vial, ampoule, syringe, or cartridge.
15. A method of manufacturing a pharmaceutical package, the method comprising:
filling a pharmaceutical container with a pharmaceutical product;
placing a sealing portion onto the pharmaceutical container; and
placing a safety seal around at least a portion of the pharmaceutical container to prevent accidental contact with any pharmaceutical product that might be present on the portion of the pharmaceutical container.
16. A method according to claim 15 , wherein placing a safety seal includes placing a blister package around the pharmaceutical container.
17. A method according to claim 15 , wherein placing a safety seal includes placing a form, fill, and seal package around the pharmaceutical container.
18. A method according to claim 15 , wherein placing a safety seal includes placing a safety seal around the entire container to prevent accidental contact with any pharmaceutical product that might be present on the container.
19. A method according to claim 15 , wherein placing a safety seal includes placing a paint-on, spray-on, or dipped rubber, rubber-like material, polymer, or polymer-like material; shrink wrap; sealing wax; or latex-type material around at least a portion of the container to prevent accidental contact with any pharmaceutical product that might be present on the container.
20. A method of removing a pharmaceutical product from a container having a safety seal, the method comprising:
placing a needle through the safety seal; and
removing the pharmaceutical product from the container through the needle.
21. A method according to claim 20 , wherein placing a needle includes placing a needle through a blister package and a sealing device of the container.
22. A method according to claim 20 , wherein placing a needle includes placing a needle through a form, fill, and seal package and a sealing device of the container.
23. A method according to claim 20 , further comprising removing a flip-cap prior to placing the needle.
24. A package comprising:
a container including a first container portion having a first surface, the container being configured and arranged to hold a hazardous product;
a sealing portion having a first sealing portion and a second sealing portion, the second sealing portion being positioned in the first container portion and the first sealing portion being in contact with the first surface; and
a safety seal encapsulating at least a portion of the product container to prevent accidental contact with any hazardous product that might be present on the portion of the container.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/324,658 US20040118802A1 (en) | 2002-12-19 | 2002-12-19 | Safety seal for potent product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/324,658 US20040118802A1 (en) | 2002-12-19 | 2002-12-19 | Safety seal for potent product |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040118802A1 true US20040118802A1 (en) | 2004-06-24 |
Family
ID=32593513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/324,658 Abandoned US20040118802A1 (en) | 2002-12-19 | 2002-12-19 | Safety seal for potent product |
Country Status (1)
Country | Link |
---|---|
US (1) | US20040118802A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070108205A1 (en) * | 2005-11-03 | 2007-05-17 | Bristol-Myers Squibb Company | Protective outer enclosure for pharmaceutical vial |
US8959765B2 (en) | 2012-07-26 | 2015-02-24 | Caterpillar Inc. | Method for making a temporary turbocharger compressor seal and temporary turbocharger compressor seal made by same |
WO2016040606A1 (en) * | 2014-09-11 | 2016-03-17 | Orventions Llc | Sterile medication identification and labeling system |
US10017302B2 (en) * | 2014-08-08 | 2018-07-10 | Richard Keith Roese | Cap and tear ring for beverage bottle |
Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1664635A (en) * | 1923-11-12 | 1928-04-03 | American Can Co | Milk-bottle closure and method of applying same |
US1969453A (en) * | 1933-01-16 | 1934-08-07 | Eastman Kodak Co | Packaging method |
US2127548A (en) * | 1935-08-13 | 1938-08-23 | James F Boyle | Method of treating containers |
US3463307A (en) * | 1967-10-06 | 1969-08-26 | Nysco Lab Inc | Display package |
US3811591A (en) * | 1971-10-19 | 1974-05-21 | New England Nuclear Corp | Dually sealable, non-leaking vial for shipping radioactive materials |
US3934746A (en) * | 1973-11-08 | 1976-01-27 | Lilja Duane F | Fluid product reservoir |
US4155454A (en) * | 1977-01-12 | 1979-05-22 | Schering Corporation | Safety packaging for ampoules |
US4181223A (en) * | 1978-05-25 | 1980-01-01 | Johnson & Johnson | Self-packaged medical device with frangible seal |
US4436203A (en) * | 1983-05-10 | 1984-03-13 | Joy Research Incorporated | Tamper resistant packaging device |
US4449631A (en) * | 1983-03-07 | 1984-05-22 | Nat Levenberg | Tamper proof packaging |
US4449632A (en) * | 1982-12-15 | 1984-05-22 | Marusiak Jr Frank | Tamper-proof package and method |
US4516967A (en) * | 1981-12-21 | 1985-05-14 | Kopfer Rudolph J | Wet-dry compartmental syringe |
US4546881A (en) * | 1983-08-03 | 1985-10-15 | Tasma Gerald W | Tamperproof packaging |
US4552277A (en) * | 1984-06-04 | 1985-11-12 | Richardson Robert D | Protective shield device for use with medicine vial and the like |
US4619651A (en) * | 1984-04-16 | 1986-10-28 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
US4653643A (en) * | 1986-06-07 | 1987-03-31 | 501 Safety Container Corp. | Tamper resistant package |
US4671331A (en) * | 1986-03-13 | 1987-06-09 | Lyphomed, Inc. | Cover for medicinal vial |
US4815619A (en) * | 1987-07-13 | 1989-03-28 | Turner Thomas R | Medicament vial safety cap |
US4890763A (en) * | 1987-01-27 | 1990-01-02 | Tsl, Incorporated | Tamper resistant package and method of making same |
US4947620A (en) * | 1987-12-23 | 1990-08-14 | Entrauision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
US5000804A (en) * | 1987-05-13 | 1991-03-19 | Nugent Edward L | Process for making body fluid sample collection tube composite |
US5074415A (en) * | 1990-05-11 | 1991-12-24 | Halpak Plastics, Inc. | Method and apparatus for manufacturing heat shrinkable enclosures |
US5137208A (en) * | 1990-06-29 | 1992-08-11 | Tsl Incorporated | Tamper evident package |
US5544770A (en) * | 1993-05-07 | 1996-08-13 | Travisano; Frank P. | Tamper evident seal and system |
US6050400A (en) * | 1994-06-10 | 2000-04-18 | Smithkline Beecham Plc | Package |
US6276856B1 (en) * | 1999-01-12 | 2001-08-21 | The Procter & Gamble Company | Self cleaning dip-in package for liquids |
US6822253B1 (en) * | 2003-05-09 | 2004-11-23 | Biodex Medical Systems, Inc. | Radiopharmaceutical shipping pig with encapsulated lead shielding |
US6868978B2 (en) * | 2000-02-18 | 2005-03-22 | Helvoet Pharma Belgium N.V. | Closing cap for infusion and transfusion bottles |
-
2002
- 2002-12-19 US US10/324,658 patent/US20040118802A1/en not_active Abandoned
Patent Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1664635A (en) * | 1923-11-12 | 1928-04-03 | American Can Co | Milk-bottle closure and method of applying same |
US1969453A (en) * | 1933-01-16 | 1934-08-07 | Eastman Kodak Co | Packaging method |
US2127548A (en) * | 1935-08-13 | 1938-08-23 | James F Boyle | Method of treating containers |
US3463307A (en) * | 1967-10-06 | 1969-08-26 | Nysco Lab Inc | Display package |
US3811591A (en) * | 1971-10-19 | 1974-05-21 | New England Nuclear Corp | Dually sealable, non-leaking vial for shipping radioactive materials |
US3934746A (en) * | 1973-11-08 | 1976-01-27 | Lilja Duane F | Fluid product reservoir |
US4155454A (en) * | 1977-01-12 | 1979-05-22 | Schering Corporation | Safety packaging for ampoules |
US4181223A (en) * | 1978-05-25 | 1980-01-01 | Johnson & Johnson | Self-packaged medical device with frangible seal |
US4516967A (en) * | 1981-12-21 | 1985-05-14 | Kopfer Rudolph J | Wet-dry compartmental syringe |
US4449632A (en) * | 1982-12-15 | 1984-05-22 | Marusiak Jr Frank | Tamper-proof package and method |
US4449631A (en) * | 1983-03-07 | 1984-05-22 | Nat Levenberg | Tamper proof packaging |
US4436203A (en) * | 1983-05-10 | 1984-03-13 | Joy Research Incorporated | Tamper resistant packaging device |
US4546881A (en) * | 1983-08-03 | 1985-10-15 | Tasma Gerald W | Tamperproof packaging |
US4619651A (en) * | 1984-04-16 | 1986-10-28 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
US4552277A (en) * | 1984-06-04 | 1985-11-12 | Richardson Robert D | Protective shield device for use with medicine vial and the like |
US4671331A (en) * | 1986-03-13 | 1987-06-09 | Lyphomed, Inc. | Cover for medicinal vial |
US4653643A (en) * | 1986-06-07 | 1987-03-31 | 501 Safety Container Corp. | Tamper resistant package |
US4890763A (en) * | 1987-01-27 | 1990-01-02 | Tsl, Incorporated | Tamper resistant package and method of making same |
US5000804A (en) * | 1987-05-13 | 1991-03-19 | Nugent Edward L | Process for making body fluid sample collection tube composite |
US4815619A (en) * | 1987-07-13 | 1989-03-28 | Turner Thomas R | Medicament vial safety cap |
US4947620A (en) * | 1987-12-23 | 1990-08-14 | Entrauision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
US5074415A (en) * | 1990-05-11 | 1991-12-24 | Halpak Plastics, Inc. | Method and apparatus for manufacturing heat shrinkable enclosures |
US5137208A (en) * | 1990-06-29 | 1992-08-11 | Tsl Incorporated | Tamper evident package |
US5544770A (en) * | 1993-05-07 | 1996-08-13 | Travisano; Frank P. | Tamper evident seal and system |
US6050400A (en) * | 1994-06-10 | 2000-04-18 | Smithkline Beecham Plc | Package |
US6276856B1 (en) * | 1999-01-12 | 2001-08-21 | The Procter & Gamble Company | Self cleaning dip-in package for liquids |
US6868978B2 (en) * | 2000-02-18 | 2005-03-22 | Helvoet Pharma Belgium N.V. | Closing cap for infusion and transfusion bottles |
US6822253B1 (en) * | 2003-05-09 | 2004-11-23 | Biodex Medical Systems, Inc. | Radiopharmaceutical shipping pig with encapsulated lead shielding |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070108205A1 (en) * | 2005-11-03 | 2007-05-17 | Bristol-Myers Squibb Company | Protective outer enclosure for pharmaceutical vial |
US8959765B2 (en) | 2012-07-26 | 2015-02-24 | Caterpillar Inc. | Method for making a temporary turbocharger compressor seal and temporary turbocharger compressor seal made by same |
US10017302B2 (en) * | 2014-08-08 | 2018-07-10 | Richard Keith Roese | Cap and tear ring for beverage bottle |
WO2016040606A1 (en) * | 2014-09-11 | 2016-03-17 | Orventions Llc | Sterile medication identification and labeling system |
US10111808B2 (en) | 2014-09-11 | 2018-10-30 | Orventions Llc | Sterile medication identification and labeling system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4390104A (en) | Flexible plastic sterile closure system for containers | |
CA1146609A (en) | Sealing cover and method for resealing an intravenous container | |
US4150744A (en) | Packaging | |
US4522308A (en) | Manually mountable tamper evident oral liquid dose viral and seal assembly | |
US4813541A (en) | Tamperproof package and method | |
US5114003A (en) | Tablet vial with desiccant in bottom | |
US4527703A (en) | Flexible sterile closure system for containers | |
US4467588A (en) | Separated packaging and sterile processing for liquid-powder mixing | |
US7708719B2 (en) | Medicament container, a medicament dispensing kit for administering medication and a method for packaging the same | |
US6793076B1 (en) | Glass bottle protective enclosure | |
US5615772A (en) | Medication filled syringe equipment | |
US4449640A (en) | Tamper-resistant pharmaceutical vial and cap assembly | |
US4420092A (en) | Tamper-resistant pharmaceutical vial and cap assembly | |
JP2016512455A (en) | Packaging system for oxygen sensitive drugs | |
JP2016512455A5 (en) | ||
CA1262113A (en) | Cover for medicinal vial | |
KR19980025150A (en) | Sealing blanks for syringes | |
CA2576610C (en) | Protected vial, and method for manufacturing same | |
CN101641071A (en) | Multi-compartment package | |
US20070257046A1 (en) | Packaging Insert | |
KR20110040987A (en) | A pre-filled container insert for mixing two or more ingredients for use in a pharmaceutical container system | |
US20040118802A1 (en) | Safety seal for potent product | |
JP2010515509A (en) | Storage of ampoules containing pharmaceutical formulations using sealed containers containing oxygen scavengers | |
US20070158232A1 (en) | Pill and method of adding measured quantities of ingredients to bottled water | |
Keerthi et al. | A review on packaging for different formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ROBERT BOSCH PACKAGING TECHNOLOGY, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LYSFJORD, JOHN P.;PETERSON, ALAN S.;BOUGIE, STEPHEN L.;AND OTHERS;REEL/FRAME:013797/0447;SIGNING DATES FROM 20030221 TO 20030224 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |